Home
HelpTest Code HFB Haemophilus influenzae Type B Antibody, IgG, Serum
Additional Codes
| Mayo Test ID |
|---|
| HIBS |
Reporting Name
Haemophilus influenzae B Ab, IgG, SUseful For
Assessing a patient's immunological (IgG) response to Haemophilus influenzae type B (HIB) vaccine
Assessing immunity against HIB
Aiding in the evaluation of immunodeficiency
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Specimen Type
SerumSpecimen Required
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.5 mL
Specimen Minimum Volume
0.2 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum | Refrigerated (preferred) | 7 days |
| Frozen | 7 days |
Reference Values
≥0.15 mg/L
Reference values apply to all ages.
Day(s) and Time(s) Performed
Tuesday, Thursday; 9 a.m.
Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86684
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| HIBS | Haemophilus influenzae B Ab, IgG, S | 11257-3 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 83261 | Haemophilus influenzae B Ab, IgG, S | 11257-3 |
Clinical Information
Haemophilus influenzae type B (HIB) is an encapsulated gram-negative cocco-bacillary bacterium that can cause devastating disease in young children including meningitis, bacteremia, cellulitis, epiglottitis, pneumonia, and septic arthritis.
One of the great advances in modern medicine has been the development of an effective vaccine against HIB. A patient's immunological response to HIB vaccine can be determined by measuring anti-HIB IgG antibody using this EIA technique.
Analytic Time
Same day/1 dayNY State Approved
YesMethod Name
Enzyme Immunoassay (EIA)
Computer Interface Code
PDM # 5900572